Dr Daniel Benjamin Moore, MD | |
110 Conn Ter Ste 550, Lexington, KY 40508-3206 | |
(859) 323-5867 | |
Not Available |
Full Name | Dr Daniel Benjamin Moore |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 16 Years |
Location | 110 Conn Ter Ste 550, Lexington, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356506463 | NPI | - | NPPES |
7100247340 | Medicaid | KY |
Facility Name | Location | Facility Type |
---|---|---|
University Of Kentucky Hospital | Lexington, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kentucky Medical Services Foundation, Inc | 5698689909 | 806 |
News Archive
Investigators at Children's Hospital Los Angeles have determined that in children receiving gadolinium as a contrast agent to enhance MRI examinations, signal changes attributed solely to deposition of this material in the brain are not dependent on the amount of gadolinium administered but rather these changes are seen in association with other factors such as the presence of brain tumors and treatment using brain irradiation. Results of the study were just published in the journal, Radiology.
It's a Catch-22 with potentially deadly consequences: People trying to overcome addiction can't get treatment for their pain, because the most powerful pain medicines also carry an addiction risk.
In a study appearing in the June 21 issue of JAMA, Peter Ganz, M.D., of the University of California-San Francisco, and colleagues conducted a study to develop and validate a score to predict risk of cardiovascular outcomes among patients with coronary heart disease using analysis of circulating proteins.
Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years.
› Verified 3 days ago
Entity Name | Kentucky Medical Services Foundation, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Investigators at Children's Hospital Los Angeles have determined that in children receiving gadolinium as a contrast agent to enhance MRI examinations, signal changes attributed solely to deposition of this material in the brain are not dependent on the amount of gadolinium administered but rather these changes are seen in association with other factors such as the presence of brain tumors and treatment using brain irradiation. Results of the study were just published in the journal, Radiology.
It's a Catch-22 with potentially deadly consequences: People trying to overcome addiction can't get treatment for their pain, because the most powerful pain medicines also carry an addiction risk.
In a study appearing in the June 21 issue of JAMA, Peter Ganz, M.D., of the University of California-San Francisco, and colleagues conducted a study to develop and validate a score to predict risk of cardiovascular outcomes among patients with coronary heart disease using analysis of circulating proteins.
Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years.
› Verified 3 days ago
Entity Name | Kentucky Institute For Eye Health & Surgery |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881636470 PECOS PAC ID: 6204818974 Enrollment ID: O20040605000067 |
News Archive
Investigators at Children's Hospital Los Angeles have determined that in children receiving gadolinium as a contrast agent to enhance MRI examinations, signal changes attributed solely to deposition of this material in the brain are not dependent on the amount of gadolinium administered but rather these changes are seen in association with other factors such as the presence of brain tumors and treatment using brain irradiation. Results of the study were just published in the journal, Radiology.
It's a Catch-22 with potentially deadly consequences: People trying to overcome addiction can't get treatment for their pain, because the most powerful pain medicines also carry an addiction risk.
In a study appearing in the June 21 issue of JAMA, Peter Ganz, M.D., of the University of California-San Francisco, and colleagues conducted a study to develop and validate a score to predict risk of cardiovascular outcomes among patients with coronary heart disease using analysis of circulating proteins.
Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Benjamin Moore, MD 110 Conn Ter Ste 550, Lexington, KY 40508-3206 Ph: (859) 323-5867 | Dr Daniel Benjamin Moore, MD 110 Conn Ter Ste 550, Lexington, KY 40508-3206 Ph: (859) 323-5867 |
News Archive
Investigators at Children's Hospital Los Angeles have determined that in children receiving gadolinium as a contrast agent to enhance MRI examinations, signal changes attributed solely to deposition of this material in the brain are not dependent on the amount of gadolinium administered but rather these changes are seen in association with other factors such as the presence of brain tumors and treatment using brain irradiation. Results of the study were just published in the journal, Radiology.
It's a Catch-22 with potentially deadly consequences: People trying to overcome addiction can't get treatment for their pain, because the most powerful pain medicines also carry an addiction risk.
In a study appearing in the June 21 issue of JAMA, Peter Ganz, M.D., of the University of California-San Francisco, and colleagues conducted a study to develop and validate a score to predict risk of cardiovascular outcomes among patients with coronary heart disease using analysis of circulating proteins.
Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years.
› Verified 3 days ago
David R. Kielar, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-258-5310 Fax: 859-258-5328 | |
Dr. Jon David Hammer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 120 N Eagle Creek Dr Ste 211, Lexington, KY 40509 Phone: 859-263-3030 Fax: 859-263-2491 | |
Dr. Peter John Timoney, MBBCH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Conn Ter Ste 550, Lexington, KY 40508 Phone: 859-323-5867 Fax: 859-323-1122 | |
Mohamed Magdy Khodeiry, MD, MSC Ophthalmology Medicare: Medicare Enrolled Practice Location: 110 Conn Ter Ste 550, Lexington, KY 40508 Phone: 859-323-5867 Fax: 859-323-8510 | |
John C. Sparrow, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 100 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-258-5310 Fax: 859-258-5328 | |
Dr. Jitander Singh Dudee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2351 Huguenard Drive, Suite 100, Lexington, KY 40503 Phone: 859-278-9486 Fax: 888-500-3329 | |
Alexander James Cherry, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 849-323-5867 |